Product Information: AcrySof® IQ Toric IOL

The proven performance of AcrySof® IQ Toric IOLs can allow astigmatic cataract patients to meet their vision goals with less dependence on glasses or contacts for distance vision.1,2

More than nine out of ten cataract patients achieve distance vision of 20/40 or better

Treat a Wider Range

AcrySof® IQ Toric IOLs offer spherical powers in half diopter increments from +6.0 D to +34.0 D and seven cylinder powers to treat 0.75 D to 4.11 D and greater—the greatest range available, enabling patients to attain crisp, clear distance vision with reduced dependence on glasses. With more choices than ever, it’s no wonder AcrySof® is the most trusted name in astigmatism-correcting IOLs.3

The Platform You Trust

AcrySof® IQ Toric IOLs are built on the same proven AcrySof® platform implanted over 70 million times
worldwide,3 delivering the exceptional visual performance you expect.

Toric IOL Advantages

  • Highly reliable treatment method2,4
  • Better post-op outcomes*2,4,5
  • Reduced residual refractive cylinder*1,2,4,5
  • More freedom from glasses for distance*1,2,4
  • Better bilateral uncorrected visual acuity*2
  • More effective and predictable compared to
    relaxing incisions4

*Compared to a monofocal IOL.
1. AcrySof® IQ Toric IOL Directions for Use.
2. Lane SS, Ernest P, Miller KM, Hileman KS, Harris B, Waycaster CR. Comparison of clinical and patient reported outcomes with bilateral AcrySof® Toric or spherical control intraocular lenses. J Refract Surg. 2009;25:899-901.
3. Data on file, independent third-party research. December 2011.
4. Mingo-Botín D. Comparison of toric intraocular lenses and peripheral corneal relaxing incisions to treat astigmatism during cataract surgery. J Cataract Refract Surg. 2010;36:1700-1708.

Visser N, Bauer JC, Nuijts R. Toric intraocular lenses in cataract surgery. In: Goggin M, ed. Astigmatism – Optics, Physiology and Management. InTech. 2012;267-293. Available from: